PRLB — what changed in the latest 10-Q
A section-by-section comparison of PRLB's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-10-29 vs the prior 10-Q · 2026-07-31
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +10 | −7 | ~40 | 29 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 2 |
| Controls & procedures | No paragraph-level changes | 0 | 0 | 0 | 3 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +1 | −2 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-10-29
Three Months Ended September 30,Nine Months Ended September 30,
Three Months Ended September 30,Nine Months Ended September 30,
Comparison of Three Months Ended September 30, 2026 and 2025
Revenue by reportable segment and the related changes for the three months ended September 30, 2026 and 2025 was as follows:
Research and Development. Our research and development expenses increased $0.3 million, or 2.9%, during the three months ended September 30, 2026 compared to the same period in 2025 primarily due to increases of $0.3 million in operating costs and $0.2 million in professional services, partially off…
Text removed vs the prior filing · source: 10-Q · 2026-07-31
Revenue by reportable segment and the related changes for the three months ended June 30, 2026 and 2025 were as follows:
Research and Development. Our research and development expenses decreased $0.4 million, or 3.4%, during the three months ended June 30, 2026 compared to the same period in 2025 primarily due to decreases in personnel and related costs of $0.9 million, partially offset by increases of $0.3 million in…
Costs related to exit and disposal. Costs related to disposal and exit activities are primarily driven by our decision to close certain manufacturing facilities in Germany. Our costs related to exit and disposal increased $0.8 million primarily related to the write-down of the abandoned facility rig…
Cost of Revenue. Cost of revenue increased $9.9 million, or 6.8%, for the six months ended June 30, 2026 compared to the same period in 2025, which was lower than the rate of revenue increase of 10.5% for the six months ended June 30, 2026 compared to the same period in 2025. The increase in cost of…
volume, partially offset by decreases of $0.2 million in equipment and facility related costs during the six months ended June 30, 2026 compared to the same period in 2025.
Other information
Text added vs the prior filing · source: 10-Q · 2026-10-29
During the three months ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defe…
Text removed vs the prior filing · source: 10-Q · 2026-07-31
On June 6, 2026, Daniel Schumacher, Chief Financial Officer of the Company, entered into a 10b5-1 sales plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. This 10b5-1 sales plan provides for the sale of up to 10,000 shares of the Company's common stock related…
During the three months ended June 30, 2026, no other directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense cond…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice